HGERS
CPRX

Householder Group Estate & Retirement Specialist’s Catalyst Pharmaceutical CPRX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-182
Closed -$2.13K – 1168
2023
Q3 		$2.13K Buy
+182
New +$2.43K ﹤0.01% 1065

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's CPRX Position: Q4 2023 in Review

Householder Group Estate & Retirement Specialist sold out of Catalyst Pharmaceutical (CPRX) in Q4 2023, closing a stake of 182 shares — an estimated $2.13K sold.

Householder Group Estate & Retirement Specialist first reported a position in CPRX in Q3 2023 and held it in 1 quarter. The position peaked at $2.13K in Q3 2023. 259 funds tracked by Wall St. Rank hold CPRX as of Q4 2023.

  • Householder Group Estate & Retirement Specialist reported no remaining Catalyst Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 182 Catalyst Pharmaceutical shares in Q4 2023, an estimated $2.13K.
  • Householder Group Estate & Retirement Specialist first reported a position in Catalyst Pharmaceutical in Q3 2023 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's Catalyst Pharmaceutical position peaked at $2.13K in Q3 2023.
  • 259 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2023, filed 23 Jan 2024.